These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
97 related articles for article (PubMed ID: 1687464)
1. Effects of SDZ NVI-085, a putative subtype-selective alpha 1-agonist, on canine cataplexy, a disorder of rapid eye movement sleep. Renaud A; Nishino S; Dement WC; Guilleminault C; Mignot E Eur J Pharmacol; 1991 Nov; 205(1):11-6. PubMed ID: 1687464 [TBL] [Abstract][Full Text] [Related]
2. Further characterization of the alpha-1 receptor subtype involved in the control of cataplexy in canine narcolepsy. Nishino S; Fruhstorfer B; Arrigoni J; Guilleminault C; Dement WC; Mignot E J Pharmacol Exp Ther; 1993 Mar; 264(3):1079-84. PubMed ID: 8095546 [TBL] [Abstract][Full Text] [Related]
3. Effects of central alpha-2 adrenergic compounds on canine narcolepsy, a disorder of rapid eye movement sleep. Nishino S; Haak L; Shepherd H; Guilleminault C; Sakai T; Dement WC; Mignot E J Pharmacol Exp Ther; 1990 Jun; 253(3):1145-52. PubMed ID: 1972749 [TBL] [Abstract][Full Text] [Related]
4. Is SDZ NVI-085 an alpha 1-adrenoceptor subtype-selective agonist? Büscher R; Insel PA; Michel MC Life Sci; 1994; 54(14):999-1007. PubMed ID: 7908116 [TBL] [Abstract][Full Text] [Related]
5. Effect of 5-HT1A receptor agonists and antagonists on canine cataplexy. Nishino S; Shelton J; Renaud A; Dement WC; Mignot E J Pharmacol Exp Ther; 1995 Mar; 272(3):1170-5. PubMed ID: 7891329 [TBL] [Abstract][Full Text] [Related]
6. Central alpha 1 adrenoceptor subtypes in narcolepsy-cataplexy: a disorder of REM sleep. Mignot E; Guilleminault C; Bowersox S; Frusthofer B; Nishino S; Maddaluno J; Ciaranello R; Dement WC Brain Res; 1989 Jun; 490(1):186-91. PubMed ID: 2569353 [TBL] [Abstract][Full Text] [Related]
7. The adrenoceptor agonist, SDZ NVI 085, discriminates between alpha 1A- and alpha 1B-adrenoceptor subtypes in vas deferens, kidney and aorta of the rat. Eltze M; Boer R Eur J Pharmacol; 1992 Dec; 224(2-3):125-36. PubMed ID: 1361446 [TBL] [Abstract][Full Text] [Related]
8. Sulpiride, a D2/D3 blocker, reduces cataplexy but not REM sleep in canine narcolepsy. Okura M; Riehl J; Mignot E; Nishino S Neuropsychopharmacology; 2000 Nov; 23(5):528-38. PubMed ID: 11027918 [TBL] [Abstract][Full Text] [Related]
9. Prostaglandin E2 and its methyl ester reduce cataplexy in canine narcolepsy. Nishino S; Mignot E; Fruhstorfer B; Dement WC; Hayaishi O Proc Natl Acad Sci U S A; 1989 Apr; 86(7):2483-7. PubMed ID: 2928344 [TBL] [Abstract][Full Text] [Related]
10. Role of central alpha-1 adrenoceptors in canine narcolepsy. Mignot E; Guilleminault C; Bowersox S; Rappaport A; Dement WC J Clin Invest; 1988 Sep; 82(3):885-94. PubMed ID: 2843574 [TBL] [Abstract][Full Text] [Related]